Difficulty: Medium
Average Score: 66%
Practice
The agent with negligible mineralocorticoid effect is
Correct answer
B
Rationale
The correct answer is B) Betamethasone. Betamethasone is a potent synthetic corticosteroid that exhibits minimal to no mineralocorticoid effects. This makes it a preferred choice in conditions where the goal is to avoid fluid retention and electrolyte imbalances commonly associated with mineralocorticoid activity.
Option A) Prednisone is a glucocorticoid that can also exhibit some mineralocorticoid effects, although to a lesser extent compared to natural cortisol.
Option C) Fludrocortisone is a synthetic mineralocorticoid that is specifically used to treat conditions where increased salt and water retention are needed, such as in adrenal insufficiency.
Option D) Cortisol is the endogenous glucocorticoid produced by the adrenal glands, which also has mineralocorticoid effects in the body.
Understanding the differences in the mineralocorticoid effects of various corticosteroids is crucial in clinical practice, especially in conditions like diabetes where managing fluid balance and electrolyte levels is essential. Choosing the appropriate corticosteroid with minimal mineralocorticoid activity can help prevent unwanted side effects and optimize treatment outcomes for patients with diabetes.
Option A) Prednisone is a glucocorticoid that can also exhibit some mineralocorticoid effects, although to a lesser extent compared to natural cortisol.
Option C) Fludrocortisone is a synthetic mineralocorticoid that is specifically used to treat conditions where increased salt and water retention are needed, such as in adrenal insufficiency.
Option D) Cortisol is the endogenous glucocorticoid produced by the adrenal glands, which also has mineralocorticoid effects in the body.
Understanding the differences in the mineralocorticoid effects of various corticosteroids is crucial in clinical practice, especially in conditions like diabetes where managing fluid balance and electrolyte levels is essential. Choosing the appropriate corticosteroid with minimal mineralocorticoid activity can help prevent unwanted side effects and optimize treatment outcomes for patients with diabetes.